Perthera is the leading Therapeutic Intelligence Company™ advancing precision medicine through our Perthera Report™, which precisely matches cancer patients with multiple therapeutic options ranked by highest probability of best outcome. Perthera utilizes the industry's best tests and laboratories to provide genomic, protein, transcription, phosphoprotein, germline, and other molecular alterations, combining this data with the patient's medical and treatment history, outcomes data from Perthera Report patients and comparing these to millions of cancer datasets to produce the Perthera Report.